NIAID Funding Opportunities: Non-Viral Technologies for In Vivo Delivery of Genome Editors

Funding Opportunities

• PAR-20-098, Non-Viral Technologies for In Vivo Delivery of Genome Editors (R43/R44, Clinical Trial Not Allowed)
• PAR-20-109, Non-Viral Technologies for In Vivo Delivery of Genome Editors (R41/R42, Clinical Trial Not Allowed)

For more, see NIAID Opportunities & Announcements. 

You can follow us on Twitter: @NIAIDFunding.